Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 44, 2010, Pages 18973-18978

  Schiffer, Joshua T ^a   Abu Raddad, Laith ^a   Mark, Karen E ^a   Zhu, Jia ^a,b   Selke, Stacy ^b   Koelle, David M ^a,b,c   Wald, Anna ^a,b,d   Corey, Lawrence ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c Department of Obstetrics Gynecology   (Qatar)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Infectious diseases; Mathematical modeling; Mucosal immunology; Virology

Indexed keywords

VIRUS DNA;

BIOPSY; CD8+ T LYMPHOCYTE; CELL DENSITY; CELL SURVIVAL; CONFERENCE PAPER; COPY NUMBER VARIATION; DISEASE DURATION; DISEASE SEVERITY; EPITHELIUM CELL; GENITAL SYSTEM; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; IMMUNOCOMPETENCE; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; MUCOSAL IMMUNITY; PREDICTION; PRIORITY JOURNAL; VIRUS LOAD; VIRUS REPLICATION; VIRUS SHEDDING;

HUMAN HERPESVIRUS 2; SIMPLEXVIRUS;

EID: 78650499757     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1006614107     Document Type: Article

References (35)

1. Corey L, Adams HG, Brown ZA, Holmes KK (1983) Genital herpes simplex virus infections: Clinical manifestations, course, and complications. Ann Intern Med 98: 958-972. (Pubitemid 13053413)
2. Wald A, Zeh J, Selke S, Ashley RL, Corey L (1995) Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 333:770-775.
3. Wald A, et al. (2000) Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 342:844-850.
4. Mark KE, et al. (2008) Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults. J Infect Dis 198:1141-1149.
5. + T cell viral-specific effector function and induces herpes simplex virus type 1 reactivation. J Immunol 181:969-975.
6. Decman V, Kinchington PR, Harvey SA, Hendricks RL (2005) Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression. J Virol 79:10339-10347.
7. + T cells. J Virol 81:8157-8164.
8. + T cell inhibition of HSV-1 reactivation from neuronal latency. Science 322:268-271.
9. Liu T, Khanna KM, Chen X, Fink DJ, Hendricks RL (2000) CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J Exp Med 191:1459-1466.
10. + T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation. J Exp Med 204:595-603.
11. Koelle DM, et al. (1998) Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes. J Clin Invest 101:1500-1508.
12. Zhu J, et al. (2009) Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat Med 15:886-892.
13. Schiffer JT, et al. (2009) Frequent release of low amounts of herpes simplex virus from neurons: Results of a mathematical model. Sci Transl Med 1:7ra16.
14. Magaret AS, Wald A, Huang ML, Selke S, Corey L (2007) Optimizing PCR positivity criterion for detection of herpes simplex virus DNA on skin and mucosa. J Clin Microbiol 45:1618-1620.
15. Smith CM, et al. (2004) Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity. Nat Immunol 5:1143-1148.
16. Milligan GN, Bernstein DI, Bourne N (1998) T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2. J Immunol 160:6093-6100. (Pubitemid 28298073)
17. Cunningham AL, Turner RR, Miller AC, Para MF, Merigan TC (1985) Evolution of recurrent herpes simplex lesions. An immunohistologic study. J Clin Invest 75:226-233.
18. Nakanishi Y, Lu B, Gerard C, Iwasaki A (2009) CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help. Nature 462:510-513.
19. Wakim LM, Waithman J, van Rooijen N, Heath WR, Carbone FR (2008) Dendritic cellinduced memory T cell activation in nonlymphoid tissues. Science 319:198-202.
20. Wald A, et al. (1997) Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J Clin Invest 99:1092-1097.
21. Crespi CM, Cumberland WG, Wald A, Corey L, Blower S (2007) Longitudinal study of herpes simplex virus type 2 infection using viral dynamic modelling. Sex Transm Infect 83:359-364.
22. Benedetti J, Corey L, Ashley R (1994) Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med 121:847-854.
23. Gebhardt T, et al. (2009) Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nat Immunol 10:524-530.
24. Peng T, et al. (2009) Evasion of the mucosal innate immune system by herpes simplex virus type 2. J Virol 83:12559-12568.
25. Donaghy H, et al. (2009) Role for plasmacytoid dendritic cells in the immune control of recurrent human herpes simplex virus infection. J Virol 83:1952-1961.
26. Peng T, Zhu J, Hwangbo Y, Corey L, Bumgarner RE (2008) Independent and cooperative antiviral actions of beta interferon and gamma interferon against herpes simplex virus replication in primary human fibroblasts. J Virol 82:1934-1945.
27. Liu T, Khanna KM, Carriere BN, Hendricks RL (2001) Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons. J Virol 75: 11178-11184.
28. Masopust D, Vezys V, Marzo AL, Lefrançois L (2001) Preferential localization of effector memory cells in nonlymphoid tissue. Science 291:2413-2417.
29. Hogan RJ, et al. (2001) Protection from respiratory virus infections can be mediated by antigen-specific CD4(+) T cells that persist in the lungs. J Exp Med 193:981-986.
30. + T cells persist in the lungs following recovery from respiratory virus infections. J Immunol 166:1813-1822.
31. Wherry EJ, Ahmed R (2004) Memory CD8 T-cell differentiation during viral infection. J Virol 78:5535-5545. (Pubitemid 38661640)
32. Koelle DM, et al. (2002) Expression of cutaneous lymphocyte-associated antigen by CD8(+) T cells specific for a skin-tropic virus. J Clin Invest 110:537-548.
33. + CTL in persons with frequently recurring genital herpes. J Immunol 165:1146-1152.
34. Straus SE, et al. (1997) Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: Results of a placebo-controlled vaccine trial. J Infect Dis 176:1129-1134.
35. Chao DL, Davenport MP, Forrest S, Perelson AS (2004) A stochastic model of cytotoxic T cell responses. J Theor Biol 228:227-240.